TEK2day FINANCE Open Terminal →

Envista Holdings Corporation (NVST)

NYQ · Healthcare · Medical Instruments & Supplies

$24.60 +0.41%

Closing price as of 2026-06-12 · Source: TEK2day Finance

1-Year Price History +30.4% over period
$31$28$24$21$18 2025-062025-092025-122026-032026-06

Key Metrics

Market Cap
$4.00B
Shares Outstanding
162.7M
P/S (TTM)
1.4x
P/E (TTM)
60.0x
Exchange
NYQ
Currency
USD

About Envista Holdings Corporation

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products, as well as provides DTX Studio Clinic, a software package offered with its imaging products. This segment offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.

Quarterly Financials

Metric2025-06-302025-09-302025-12-312026-03-31
Revenue682.1M669.9M750.6M705.5M
Gross Profit369.9M370.2M410.6M390.1M
Operating Income46.3M57.5M93.0M66.2M
Net Income26.4M-30.3M32.9M38.7M
Diluted EPS$0.16$-0.18$0.20$0.23

Annual Financials

Metric2022-12-312023-12-312024-12-312025-12-31
Revenue2.6B2.6B2.5B2.7B
Gross Profit1.5B1.4B1.4B1.5B
Operating Income343.2M314.9M137.2M235.8M
Net Income243.1M-100.2M-1.1B47.0M
Diluted EPS$1.37$-0.60$-6.50$0.28
Want live quotes, estimates, SEC filings, and CEO analytics for NVST?
The free TEK2day terminal runs in your browser — type /NVST to get started.
Open NVST in the Terminal →